Researchers discovered new immune response regulators

January 15, 2019

The discovery was published in the new iScience journal for interdisciplinary research by Cell Press.

The newly discovered regulatory proteins differ significantly from the regulators in mouse immune cells which have been reported earlier. Some of the proteins, such as SATB1 regulating the transcription of several genes, function in the opposite way in human compared to mouse. The findings open new, previously unknown possibilities into the treatment of immune-mediated diseases, such as multiple sclerosis or rheumatoid arthritis.

- The differences in the immune system cell regulators in mouse and human revealed by protein-level analyses are in line with our earlier findings. To understand the special characteristics of the human T cell regulation, studies on human cells are necessary to advance translational research, stresses Professor Riitta Lahesmaa.

T cells are critical in regulating the immune response. They can also cause inflammatory diseases such as multiple sclerosis or type 1 diabetes.

Researchers from Turku Centre for Biotechnology of the University of Turku and Åbo Akademi University in Finland used a proteomic approach they have optimised to discover how protein levels in T cells change over time so that they start causing inflammation.

The team identified new cell regulators and gained information on the cell differentiation process, which can be a starting point for planning new ways of preventing cells from becoming inflammatory.
-end-


University of Turku

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.